122 related articles for article (PubMed ID: 3105266)
21. Three-year experience with NORPLANT subdermal contraception.
Sivin I; Sanchez FA; Diaz S; Holma P; Coutinho E; McDonald O; Robertson DN; Stern J
Fertil Steril; 1983 Jun; 39(6):799-808. PubMed ID: 6406273
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with the acceptance of Norplant or IUD among women with similar socio-demographic characteristics.
Hardy E; Goodson P; De Souza TR; Rodriguez CM
Adv Contracept; 1991 Mar; 7(1):95-105. PubMed ID: 1908179
[TBL] [Abstract][Full Text] [Related]
23. Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
Tankeyoon M; Dusitsin N; Chalapati S; Koetsawang S; Saibiang S; Sas M; Gellen JJ; Ayeni O; Gray R; Pinol A
Contraception; 1984 Dec; 30(6):505-22. PubMed ID: 6241559
[TBL] [Abstract][Full Text] [Related]
24. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
25. Endometrial angiogenic response in Norplant users.
Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
[TBL] [Abstract][Full Text] [Related]
26. New IPPF statement on breastfeeding, fertility and post-partum contraception.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
[TBL] [Abstract][Full Text] [Related]
27. Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices.
Díaz S; Zepeda A; Maturana X; Reyes MV; Miranda P; Casado ME; Peralta O; Croxatto HB
Contraception; 1997 Oct; 56(4):223-32. PubMed ID: 9408703
[TBL] [Abstract][Full Text] [Related]
28. Norplant-2 rods contraceptive subdermal implants: two-year experience in Singapore.
Singh K; Viegas OA; Singh P; Ratnam SS
Adv Contracept; 1989 Jun; 5(2):91-9. PubMed ID: 2512771
[TBL] [Abstract][Full Text] [Related]
29. Hormonal contraception and lactation.
Kelsey JJ
J Hum Lact; 1996 Dec; 12(4):315-8. PubMed ID: 9025449
[TBL] [Abstract][Full Text] [Related]
30. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
Olsson SE; Odlind V; Johansson ED; Nordström ML
Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
[TBL] [Abstract][Full Text] [Related]
31. Effects of hormonal and nonhormonal contraceptives on lactation and incidence of pregnancy.
Zacharias S; Aguilera E; Assenzo JR; Zanartu J
Contraception; 1986 Mar; 33(3):203-13. PubMed ID: 2941236
[TBL] [Abstract][Full Text] [Related]
32. The effects of a progestin-only oral contraceptive (levonorgestrel 0.03 mg) on breast-feeding.
McCann MF; Moggia AV; Higgins JE; Potts M; Becker C
Contraception; 1989 Dec; 40(6):635-48. PubMed ID: 2515939
[TBL] [Abstract][Full Text] [Related]
33. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
34. Estradiol plasma levels during long-term treatment with Norplant subdermal implants.
Croxatto HB; Díaz S; Pavez M; Brandeis A
Contraception; 1988 Oct; 38(4):465-75. PubMed ID: 3145171
[TBL] [Abstract][Full Text] [Related]
35. Contraceptive implants and lactation.
Díaz S
Contraception; 2002 Jan; 65(1):39-46. PubMed ID: 11861054
[TBL] [Abstract][Full Text] [Related]
36. Subjective perception of bleeding and serum ferritin concentration in long-term users of Norplant.
Faundes A; Tejada AS; Brache V; Alvarez F
Contraception; 1987 Feb; 35(2):189-96. PubMed ID: 3109804
[TBL] [Abstract][Full Text] [Related]
37. Immediate postpartum insertion of the norplant contraceptive device.
Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
[TBL] [Abstract][Full Text] [Related]
38. Norplant: subdermal implant system for long-term contraception.
Shoupe D; Mishell DR
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1286-92. PubMed ID: 2497646
[TBL] [Abstract][Full Text] [Related]
39. Association between contraceptive method accepted and perception of information received: a comparison of Norplant and IUD acceptors.
Hardy E; Goodson P
Contraception; 1991 Feb; 43(2):121-8. PubMed ID: 1904019
[TBL] [Abstract][Full Text] [Related]
40. Study of the effects of the implantable contraceptive Norplant on lipid and lipoprotein metabolism. UN Development Programme/UN Population Fund/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Contraception; 1999 Jan; 59(1):31-45. PubMed ID: 10342084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
